Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-14 Sale |
2024-02-16 6:28 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $16.76 | $251,349 | 534,389 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 6:39 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
45,000 | $15.18 | $682,992 | 549,389 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-04 4:23 pm |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
17,237 | $17.39 | $299,789 | 158,067 (Direct) |
View |
| 2023-12-19 Sale |
2023-12-21 1:38 pm |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
45,000 | $19.68 | $885,825 | 577,959 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 4:06 pm |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
3,138 | $22.17 | $69,559 | 146,918 (Direct) |
View |
| 2022-08-30 Sale |
2022-08-31 6:01 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
2,400 | $30.24 | $72,573 | 135,160 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-08 4:04 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
17,680 | $35.18 | $622,035 | 137,560 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 5:26 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
2,400 | $31.25 | $75,012 | 155,240 (Direct) |
View |
| 2022-07-13 Sale |
2022-07-15 4:18 pm |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
4,800 | $30.01 | $144,028 | 157,640 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-14 Exercise |
2024-02-16 6:28 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $0 | 534,389 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 6:28 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
15,000 | $3.76 | 534,389 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 6:39 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
45,000 | $0 | 549,389 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 6:39 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
45,000 | $3.76 | 549,389 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:34 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer |
8,120 | $17.95 | 184,377 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:34 pm |
N/A 2034-01-02 |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer |
99,512 | $0 | 184,377 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:23 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
10,385 | $17.95 | 158,067 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:23 pm |
N/A 2034-01-02 |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
82,926 | $0 | 158,067 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
8,410 | $17.95 | 185,903 (Direct) |
View |
| 2022-06-30 Option Award |
2024-01-04 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
728 | $21 | 185,903 (Direct) |
View |
| 2023-06-30 Option Award |
2024-01-04 4:22 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
1,123 | $16.99 | 185,903 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:22 pm |
N/A 2034-01-02 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
99,512 | $0 | 185,903 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:17 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
4,534 | $17.95 | 302,806 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:17 pm |
N/A 2034-01-02 |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
92,339 | $0 | 302,806 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:07 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
11,357 | $17.95 | 713,285 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:07 pm |
N/A 2034-01-02 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
369,353 | $0 | 713,285 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
7,893 | $17.95 | 170,704 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:06 pm |
N/A 2034-01-02 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
89,560 | $0 | 170,704 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-21 1:38 pm |
N/A 2025-05-19 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
45,000 | $0 | 577,959 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-21 1:38 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
1,500 | $0.85 | 577,959 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-21 1:38 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
43,500 | $3.76 | 577,959 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:14 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | Fox Allan M. Director |
21,378 | $0 | 2,906,854 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:13 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | Tasse Daniel Director |
21,378 | $0 | 24,388 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:12 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | STUMP DAVID C Director |
21,378 | $0 | 24,388 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:12 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director |
21,378 | $0 | 24,388 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:12 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director |
21,378 | $0 | 24,388 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:12 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
21,378 | $0 | 24,388 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:11 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | Bennett Jean Director |
21,378 | $0 | 24,388 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 5:11 pm |
N/A 2033-06-02 |
REGENXBIO Inc. | RGNX | Zachary Jennifer Director |
21,378 | $0 | 27,398 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-02 4:12 pm |
N/A 2024-09-24 |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
35,000 | $0 | 215,001 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-02 4:12 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
35,000 | $0.85 | 215,001 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
1,333 | $22.68 | 246,234 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
112,407 | $0 | 246,234 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer |
2,076 | $22.68 | 145,971 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer |
120,931 | $0 | 145,971 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
1,837 | $22.68 | 146,918 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer |
134,743 | $0 | 146,918 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
2,058 | $22.68 | 145,936 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer |
118,916 | $0 | 145,936 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
9,308 | $22.68 | 620,221 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO |
319,685 | $0 | 620,221 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 4:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
1,843 | $22.68 | 145,556 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-03 |
REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer |
124,459 | $0 | 145,556 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:26 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | Zachary Jennifer Director |
35,759 | $0 | 35,759 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:23 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | Tasse Daniel Director |
18,334 | $0 | 18,334 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:22 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | STUMP DAVID C Director |
18,334 | $0 | 18,334 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:21 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director |
18,334 | $0 | 18,334 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:20 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director |
18,334 | $0 | 18,334 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:18 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director |
18,334 | $0 | 18,334 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:17 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | Fox Allan M. Director |
18,334 | $0 | 18,334 (Direct) |
View |
| 2022-06-03 Option Award |
2022-06-07 4:16 pm |
N/A 2032-06-03 |
REGENXBIO Inc. | RGNX | Bennett Jean Director |
18,334 | $0 | 18,334 (Direct) |
View |
| 2022-01-20 Exercise |
2022-01-24 4:25 pm |
N/A 2024-09-23 |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
29,900 | $0 | 197,440 (Direct) |
View |
| 2022-01-20 Exercise |
2022-01-24 4:25 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
29,900 | $0.85 | 197,440 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 9:07 pm |
N/A 2032-01-03 |
REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer |
51,400 | $0 | 175,040 (Direct) |
View |
| 2022-01-01 Tax Withholding |
2022-01-04 9:06 pm |
N/A N/A |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer |
1,332 | $32.7 | 78,216 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 9:06 pm |
N/A 2032-01-03 |
REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer |
61,800 | $0 | 78,216 (Direct) |
View |